Year |
Citation |
Score |
2012 |
Leman ES, Magheli A, Cannon GW, Mangold L, Partin AW, Getzenberg RH. Erratum: Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2 (Prostate (2009) 69 (1188-1194)) The Prostate. 72. PMID 22803194 DOI: 10.1002/Pros.22529 |
0.763 |
|
2012 |
Leman E, Huang W, Contreras-Trujillo H, Volksmer J, Willingham S, Barron A, Gonzalgo M. 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1178 |
0.356 |
|
2009 |
Leman ES, Magheli A, Yong KM, Netto G, Hinz S, Getzenberg RH. Identification of nuclear structural protein alterations associated with seminomas. Journal of Cellular Biochemistry. 108: 1274-9. PMID 19795381 DOI: 10.1002/Jcb.22357 |
0.561 |
|
2009 |
Leman ES, Getzenberg RH. Biomarkers for prostate cancer. Journal of Cellular Biochemistry. 108: 3-9. PMID 19507229 DOI: 10.1002/Jcb.22227 |
0.757 |
|
2009 |
Leman ES, Magheli A, Cannon GW, Mangold L, Partin AW, Getzenberg RH. Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2 Prostate. 69: 1188-1194. PMID 19418497 DOI: 10.1002/Pros.20963 |
0.721 |
|
2009 |
Inoue T, Maeno A, Talbot C, Zeng Y, Yeater DB, Leman ES, Kulkarni P, Ogawa O, Getzenberg RH. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells. The Prostate. 69: 861-73. PMID 19267365 DOI: 10.1002/Pros.20936 |
0.728 |
|
2009 |
Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. W1889 Blood-Based Detection of Colon Cancer Utilizing Specific Nuclear Matrix Proteins Gastroenterology. 136: A-748. DOI: 10.1016/S0016-5085(09)63448-X |
0.615 |
|
2009 |
Inoue T, Maeno A, Kulkarni P, Zeng Y, Yeater D, Leman E, Ogawa O, Getzenberg R. POD-04.01: Purine-Rich Element Binding Protein Alpha Induces Cell Stress and Differentiation Pathways in Prostate Cancer Cells Urology. 74: S10. DOI: 10.1016/j.urology.2009.07.1177 |
0.652 |
|
2008 |
Inoue T, Leman ES, Yeater DB, Getzenberg RH. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer. The Prostate. 68: 1048-56. PMID 18386260 DOI: 10.1002/Pros.20764 |
0.728 |
|
2008 |
Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer Clinical Cancer Research. 14: 1349-1354. PMID 18316554 DOI: 10.1158/1078-0432.Ccr-07-4110 |
0.619 |
|
2008 |
Walgenbach-Brunagel G, Burger B, Leman ES, Walgenbach KJ, Tolba R, Heukamp L, Hirner A, Getzenberg RH. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer. Journal of Cellular Biochemistry. 104: 286-94. PMID 18044711 DOI: 10.1002/Jcb.21619 |
0.625 |
|
2008 |
Leman ES, Getzenberg RH. Nuclear structure as a source of cancer specific biomarkers. Journal of Cellular Biochemistry. 104: 1988-93. PMID 17455233 DOI: 10.1002/Jcb.21363 |
0.681 |
|
2008 |
Leman ES, Magheli A, Cannon GW, Sokoll LJ, Chan DW, Mangold LA, Partin AW, Getzenberg RH, Getzenberg RH. ANALYSIS OF A SECOND EPCA-2 EPITOPE AS A SERUM TEST FOR PROSTATE CANCER Journal of Urology. 179: 704-704. DOI: 10.1016/S0022-5347(08)62052-2 |
0.757 |
|
2008 |
Inoue T, Leman ES, Yeater D, Getzenberg RH. PURINE-ELEMENT BINDING PROTEIN (PUR) α AS A NOVEL TREATMENT TARGET FOR HORMONE-REFRACTORY PROSTATE CANCER Journal of Urology. 179: 46-47. DOI: 10.1016/S0022-5347(08)60140-8 |
0.709 |
|
2008 |
Christodouleas J, Yeater D, Jabbour S, Mangold L, Leman E, Drew R, Humphreys E, Partin A, Getzenberg R, DeWeese T. Modulation of EPCA-2 Levels in Men with Localized Prostate Cancer Treated with Radiation with or without Androgen Suppression Therapy International Journal of Radiation Oncology*Biology*Physics. 72: S316. DOI: 10.1016/J.Ijrobp.2008.06.1091 |
0.672 |
|
2007 |
Leman ES, Schoen RE, Weissfeld JL, Cannon GW, Sokoll LJ, Chan DW, Getzenberg RH. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Research. 67: 5600-5. PMID 17575123 DOI: 10.1158/0008-5472.Can-07-0649 |
0.589 |
|
2007 |
Leman ES, Cannon GW, Trock BJ, Sokoll LJ, Chan DW, Mangold L, Partin AW, Getzenberg RH. EPCA-2: a highly specific serum marker for prostate cancer. Urology. 69: 714-20. PMID 17445657 DOI: 10.1016/J.Urology.2007.01.097 |
0.76 |
|
2007 |
Leman ES, Cannon GW, Track BJ, Sokoll LJ, Chan DW, Mangold LA, Partin AW, Nickel JC, Dimitrakov JD, Getzenberg RH. 1431: Further Analysis of Serum Based EPCA-2 as a Specific Prostate Cancer Associated Biomarker Journal of Urology. 177: 472-472. DOI: 10.1016/S0022-5347(18)31632-X |
0.759 |
|
2003 |
Kasai M, Guerrero-Santoro J, Friedman R, Leman ES, Getzenberg RH, DeFranco DB. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Research. 63: 4927-35. PMID 12941817 |
0.58 |
|
2003 |
Leman ES, Arlotti JA, Dhir R, Getzenberg RH. Vitamin D and androgen regulation of prostatic growth. Journal of Cellular Biochemistry. 90: 138-47. PMID 12938163 DOI: 10.1002/Jcb.10605 |
0.68 |
|
2003 |
Leman ES, DeMiguel F, Gao AC, Getzenberg RH. Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells. The Journal of Urology. 170: 235-40. PMID 12796696 DOI: 10.1097/01.Ju.0000060117.61770.35 |
0.664 |
|
2003 |
Leman ES, Getzenberg RH. Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cells. Journal of Cellular Biochemistry. 88: 609-22. PMID 12532336 DOI: 10.1002/Jcb.10371 |
0.687 |
|
2003 |
Leman ES, Madigan MC, Brünagel G, Takaha N, Coffey DS, Getzenberg RH. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 88: 599-608. PMID 12532335 DOI: 10.1002/Jcb.10368 |
0.746 |
|
2002 |
Leman ES, Getzenberg RH. Nuclear matrix proteins as biomarkers in prostate cancer. Journal of Cellular Biochemistry. 86: 213-23. PMID 12111991 DOI: 10.1002/Jcb.10218 |
0.751 |
|
2002 |
Leman ES, Arlotti JA, Dhir R, Greenberg N, Getzenberg RH. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry. 86: 203-12. PMID 12111990 DOI: 10.1002/Jcb.10216 |
0.751 |
|
2001 |
Leman ES, Sisken BF, Zimmer S, Anderson KW. Studies of the interactions between melatonin and 2 Hz, 0.3 mT PEMF on the proliferation and invasion of human breast cancer cells. Bioelectromagnetics. 22: 178-84. PMID 11255213 DOI: 10.1002/Bem.36 |
0.336 |
|
2000 |
KONETY BR, LEMAN E, VIETMEIER B, ARLOTTI J, DHIR R, GETZENBERG RH. IN VITRO AND IN VIVO EFFECTS OF VITAMIN D (CALCITRIOL) ADMINISTRATION ON THE NORMAL NEONATAL AND PREPUBERTAL PROSTATE Journal of Urology. 164: 1812-1818. DOI: 10.1016/S0022-5347(05)67112-1 |
0.723 |
|
Show low-probability matches. |